Nonclinical & Clinical PK & PD Modeling of HDP-101, an Amanitin Based ADC in Order to Optimize Dosing in the Phase I Clinical Trial
Time: 12:00 pm
day: Conference Day 1
Details:
- Comparing clinical and nonclinical PK-PD data
- Building PD models based on collective data
- Running different dosing on models to select clinical strategy
